Discounted Cash Flow

Bristol Myers Squibb Co.

BMY · Based on 10 years of SEC filings · Converted from EUR to USD

⚠ Cash flow predictability 65/100 (moderate) — FCF YoY std dev 39%, net income 80% (full history)

DCF estimate unavailable — loss_in_2024

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income
Dividends

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $22.6b $5.2b $1.9b 22.9% $2.67
2017 $24.1b (6.9%) $1.2b (-77.4%) $4.9b (158.1%) 4.8% (-78.9%) $0.61 (-77.2%)
2018 $26.2b (8.6%) $5.7b (388.6%) $5.8b (18.2%) 21.8% (349.9%) $3.01 (393.4%)
2019 $30.4b (15.9%) $4.0b (-30.1%) $8.4b (44.9%) 13.2% (-39.7%) $2.02 (-32.9%)
2020 $49.4b (62.6%) $-10.5b (-362.1%) $15.4b (83.9%) -21.2% (-261.2%) $-3.99 (-297.5%)
2021 $53.9b (9.1%) $8.1b (177.6%) $17.7b (14.5%) 15.1% (171.1%) $3.15 (178.9%)
2022 $53.6b (-0.5%) $7.3b (-9.5%) $13.9b (-21.6%) 13.7% (-9.1%) $2.97 (-5.7%)
2023 $52.3b (-2.5%) $9.3b (26.8%) $14.7b (5.9%) 17.8% (30.1%) $3.88 (30.6%)
2024 $56.1b (7.3%) $-10.4b (-211.5%) $16.2b (10.2%) -18.5% (-203.9%) $-4.41 (-213.7%)
2025 $56.0b (-0.2%) $8.2b (178.8%) $14.9b (-7.9%) 14.6% (179.0%) $3.47 (178.7%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

SEC filings report in EUR. Values above are converted to USD for comparison with the US-listed share price.

Values abbreviated: b = billions, m = millions, k = thousands.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

loss_in_2024

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.